Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdissa Negassa

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 30, 2008
Estrogen plus progestin and risk of benign proliferative breast diseaseThomas E Rohan, Abdissa Negassa, Rowan T Chlebowski, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 31, 2012
Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patientsEugene J Fine, C J Segal-Isaacson, Richard D Feinman, et al.
Breast Cancer Research and Treatment|October 15, 2008
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast diseaseThomas E Rohan, Abdissa Negassa, Rowan T Chlebowski, et al.
European Journal of Heart Failure|May 29, 2007
Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changesAndrew L Clark, Christoph Knosalla, Emma Birks, et al.
European Heart Journal|May 13, 2005
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertensionChristian F Opitz, Roland Wensel, Jörg Winkler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trialThomas E Rohan, Abdissa Negassa, Bette Caan, et al.
Clinical Colorectal Cancer|April 17, 2017
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal CancerSanjay Goel, Abdissa Negassa, Ashish Khot, et al.
Cancer Research|June 18, 2003
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesisMark D'Amico, Kongming Wu, Dolores Di Vizio, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
Breast Cancer Research and Treatment|June 7, 2014
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancerYifan Tu, Dawn L Hershman, Kapil Bhalla, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 30, 2008
Estrogen plus progestin and risk of benign proliferative breast diseaseThomas E Rohan, Abdissa Negassa, Rowan T Chlebowski, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 31, 2012
Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patientsEugene J Fine, C J Segal-Isaacson, Richard D Feinman, et al.
Breast Cancer Research and Treatment|October 15, 2008
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast diseaseThomas E Rohan, Abdissa Negassa, Rowan T Chlebowski, et al.
European Journal of Heart Failure|May 29, 2007
Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changesAndrew L Clark, Christoph Knosalla, Emma Birks, et al.
European Heart Journal|May 13, 2005
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertensionChristian F Opitz, Roland Wensel, Jörg Winkler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trialThomas E Rohan, Abdissa Negassa, Bette Caan, et al.
Clinical Colorectal Cancer|April 17, 2017
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal CancerSanjay Goel, Abdissa Negassa, Ashish Khot, et al.
Cancer Research|June 18, 2003
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesisMark D'Amico, Kongming Wu, Dolores Di Vizio, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
Breast Cancer Research and Treatment|June 7, 2014
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancerYifan Tu, Dawn L Hershman, Kapil Bhalla, et al.
Pageof 7